HGHRX Mutual Fund

NAV$42.01
Showing top 15 of 84 holdingsSee all 84 holdings(as of Jan 31, 2026)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgPROSectorPROIndustryPRO
1LLYEli Lilly And Company13.12%105,506$109.43M-14.8KHealth CarePharmaceuticals
2MRKMerck & Co. Inc.5.74%434,365$47.90M+41.6KHealth CarePharmaceuticals
3JNJJOHNSON AND JOHNSON5.07%186,167$42.31MProProPro
4UNHUnited Health Group4.64%134,871$38.70MProProPro
5ABBVAbbvie Inc Health Care3.84%143,697$32.05MProProPro
6ISRGIntuitive Surgical Inc - Common3.51%58,069$29.28MProProPro
7DHRDanaher Corporation3.06%116,573$25.52MProProPro
8ABTAbbott Laboratories2.95%225,393$24.64MProProPro
9EWEdwards Lifesciences Corp2.83%290,008$23.60MProProPro
10CORCencora Inc2.72%63,164$22.69MProProPro
11MDT:IEMedtronic Plc2.71%219,940$22.65MProProPro
12VRTXVertex Pharmaceuticals Inc2.46%43,668$20.52MProProPro
13TMOThermo Fisher Scientific Inc1.88%27,039$15.65MProProPro
14ANTMAnthem  Inc .1.76%42,513$14.70MProProPro
15HCAHca Holdings Inc1.59%27,119$13.24MProProPro
See the other 69 holdings of HGHRX
Every position with sector, industry and share changes, as reported Jan 31, 2026.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

HGHRX Mutual Fund All Holdings

HGHRX holdings total 84 positions. The top 10 holdings account for 47.5% of the fund, led by Eli Lilly And Company at 13.1%, Merck & Co. Inc. at 5.7%, JOHNSON AND JOHNSON at 5.1%.

HGHRX portfolio concentration is moderate, with the top 10 representing 47.5% of total assets. The largest sector exposure is Health Care at 84.0%.

HGHRX sector allocation provides a detailed breakdown. HGHRX overlap tool shows how holdings compare to other funds in your portfolio.